iBio (IBIO) Receivables - Other (2011 - 2024)
iBio (IBIO) recorded Receivables - Other of $14.1 million in fiscal Q3 2024 (quarter ended Mar 31, 2024), up 176.5% from $5.1 million a year earlier.
Powered by 
Analysis
iBio (IBIO) Receivables - Other (2011 - 2024) Analysis & Trends
At the end of FY2023 (ended Jun 30, 2023), iBio reported Receivables - Other of $204,000, down 96.0% from FY2022.
- Annual Receivables - Other has a three-year compound annual growth rate of -66.7% (FY2020 to FY2023).
- Across earlier fiscal years, Receivables - Other came in at $5.1 million in FY2022 (unchanged), $5.1 million in FY2021 (-8.1%) and $5.55 million in FY2020.
- The fiscal Q3 2024 figure is the highest quarterly Receivables - Other in data going back to fiscal Q1 2015.
- On a year-over-year basis, Receivables - Other rose in 1 of the last four quarters, with growth averaging 44.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 14.10 Mn |
| Mar 31, 2023 | 5.10 Mn |
| Dec 31, 2022 | 5.10 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Mar 31, 2022 | 5.10 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 5.10 Mn |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 52,000.00 |
| Dec 31, 2018 | 57,000.00 |
| Dec 31, 2016 | 75,000.00 |
| Sep 30, 2016 | 62,000.00 |
| Jun 30, 2016 | 122,000.00 |
| Dec 31, 2015 | 15,000.00 |
| Sep 30, 2015 | 126,000.00 |
| Mar 31, 2015 | 325,000.00 |
| Dec 31, 2014 | 338,000.00 |
| Sep 30, 2014 | 555,000.00 |
| Jun 30, 2012 | 177,379.00 |
| Jun 30, 2011 | 222,769.00 |
API Access
iBio Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();